| Translated title of the contribution | Cost-Effectiveness Analysis of Adjuvant Osimertinib in Taiwanese Patients with Resected Stage IIIA EGFR-Mutation Positive Non-Small Cell Lung Cancer |
|---|---|
| Original language | Chinese (Traditional) |
| Supervisors/Advisors |
|
| State | Published - 2025 |
| Externally published | Yes |
台灣EGFR突變陽性第IIIA期非小細胞肺癌患者於手術切除後進行Osimertinib輔助治療的成本效益分析
陳柏豪
Research output: Types of Thesis › Master's thesis